ASTH
Astrana Health, Inc.
Company overview
- Market capitalization
- $1.96B
- Employees
- 3,000
- Latest publication
- 2026-09-29
About Astrana Health, Inc.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Financial statements
Income Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q1 20232023-03-31 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 950,526,000USD | 956,048,000USD | 654,808,000USD | 620,390,000USD | 665,209,000USD | 337,244,000USD | 317,001,000USD | 269,697,000USD |
| Cost Of Revenue | 871,884,000USD | 874,451,000USD | 576,839,000USD | 549,061,000USD | 602,193,000USD | 289,397,000USD | 240,768,000USD | 230,070,000USD |
| Gross Profit | 78,642,000USD | 81,597,000USD | 77,969,000USD | 71,329,000USD | 63,016,000USD | 47,847,000USD | 76,233,000USD | 39,627,000USD |
| Selling General Administrative | 9,522,000USD | 113,112,000USD | 50,725,000USD | 43,897,000USD | 41,633,000USD | 21,182,000USD | 21,388,000USD | 19,894,000USD |
| Unclassified Operating Expenses | 50,725,000USD | -50,725,000USD | 6,904,000USD | 6,849,000USD | 20,663,000USD | 4,292,000USD | 4,754,000USD | 4,351,000USD |
| Total Operating Expenses | 60,247,000USD | 62,387,000USD | 57,629,000USD | 50,746,000USD | 62,296,000USD | 25,474,000USD | 26,142,000USD | 24,245,000USD |
| Operating Income | 18,395,000USD | 19,210,000USD | 20,340,000USD | 20,583,000USD | 720,000USD | 22,373,000USD | 50,091,000USD | 15,382,000USD |
| Interest Income | 3,987,000USD | 3,522,000USD | 2,336,000USD | 2,312,000USD | 3,221,000USD | 3,009,000USD | 223,000USD | 421,000USD |
| Interest Expense | 17,520,000USD | 17,718,000USD | 7,382,000USD | 7,308,000USD | 8,069,000USD | 3,269,000USD | 2,422,000USD | 1,854,000USD |
| Net Interest Income | -13,533,000USD | -14,196,000USD | -5,046,000USD | -4,996,000USD | -4,848,000USD | -260,000USD | -2,199,000USD | -1,433,000USD |
| Income Before Tax | 7,506,000USD | 5,671,000USD | 16,825,000USD | 9,604,000USD | -1,895,000USD | 19,409,000USD | 41,263,000USD | 16,629,000USD |
| Income Tax Expense | 944,000USD | 4,594,000USD | 6,609,000USD | 3,383,000USD | 5,882,000USD | 6,921,000USD | 17,366,000USD | 5,352,000USD |
| Tax Provision | 944,000USD | 4,594,000USD | 6,609,000USD | 3,383,000USD | 5,882,000USD | 5,102,000USD | 13,867,000USD | 6,038,000USD |
| Net Income | 5,999,000USD | 373,000USD | 9,423,000USD | 6,692,000USD | -6,951,000USD | 13,132,000USD | 23,185,000USD | 11,950,000USD |
| Net Income From Continuing Ops | 6,562,000USD | 1,077,000USD | 10,216,000USD | 6,221,000USD | -7,777,000USD | 14,307,000USD | 27,396,000USD | 10,591,000USD |
| Ebit | 25,026,000USD | 23,389,000USD | 24,207,000USD | 16,912,000USD | 6,174,000USD | 22,678,000USD | 43,685,000USD | 18,483,000USD |
| Ebitda | 41,427,000USD | 38,984,000USD | 31,111,000USD | 23,761,000USD | 14,300,000USD | 26,970,000USD | 48,440,000USD | 22,834,000USD |
| Depreciation And Amortization | 16,401,000USD | 15,595,000USD | 6,904,000USD | 6,849,000USD | 8,126,000USD | 4,292,000USD | 4,755,000USD | 4,351,000USD |
| Reconciled Depreciation | 16,401,000USD | 15,596,000USD | 6,903,000USD | 6,849,000USD | 8,126,000USD | 4,292,000USD | 4,754,000USD | 4,351,000USD |
| Total Other Income Expense Net | -10,889,000USD | -13,539,000USD | -3,515,000USD | -10,979,000USD | -2,615,000USD | -2,964,000USD | -8,828,000USD | 1,247,000USD |
| Minority Interest | -563,000USD | -704,000USD | -793,000USD | 471,000USD | 826,000USD | -315,000USD | 1,410,000USD | -808,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 305,000USD | -6,406,000USD | 3,101,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | 14,622,000USD | 25,986,000USD | 11,399,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-12-31 · USD | FY 20142014-12-31 · USD | FY 20112011-12-31 · USD | FY 20102010-12-31 · USD | FY 20092009-12-31 · USD | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,144,163,000USD | 32,989,742USD | 5,110,806USD | 3,896,584USD | 2,441,452USD | 1,057,354USD | 100,000USD | — |
| Cost Of Revenue | 944,685,000USD | 22,067,421USD | 4,132,399USD | 3,314,722USD | 1,813,944USD | 1,046,103USD | 100,000USD | — |
| Gross Profit | 199,478,000USD | 10,922,321USD | 978,407USD | 581,862USD | 627,508USD | 11,251USD | — | — |
| Selling General Administrative | 77,670,000USD | 11,282,221USD | 1,379,153USD | 566,649USD | 694,319USD | 827,287USD | 36,651USD | 27,484USD |
| Unclassified Operating Expenses | 17,543,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 95,213,000USD | 11,616,655USD | 1,391,742USD | 577,847USD | 730,023USD | 847,067USD | 36,651USD | 27,484USD |
| Operating Income | 104,265,000USD | -694,334USD | -413,335USD | 4,015USD | -102,515USD | -835,816USD | -36,651USD | -27,484USD |
| Interest Income | 1,976,000USD | — | — | — | — | — | — | — |
| Interest Expense | 7,920,000USD | 0USD | 304,034USD | 126,431USD | 53,128USD | 55,200USD | 36,651USD | 27,484USD |
| Net Interest Income | -5,944,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 86,616,000USD | -1,184,165USD | -714,527USD | -154,731USD | -195,280USD | -891,015USD | -36,651USD | -27,484USD |
| Income Tax Expense | 40,875,000USD | 163,792USD | 5,819USD | 1,600USD | 800USD | 800USD | 36,651USD | 27,484USD |
| Tax Provision | 36,085,000USD | — | — | — | — | — | — | — |
| Net Income | 45,171,000USD | -1,802,601USD | -720,346USD | -156,331USD | -196,080USD | -891,815USD | -36,651USD | -27,484USD |
| Net Income From Continuing Ops | 50,531,000USD | -1,347,957USD | -720,346USD | — | — | — | — | — |
| Ebit | 94,536,000USD | -694,334USD | -410,493USD | 4,015USD | -102,514USD | -835,815USD | -36,651USD | -27,484USD |
| Ebitda | 112,079,000USD | -359,900USD | -397,904USD | 15,213USD | -66,811USD | -816,035USD | -36,651USD | -27,484USD |
| Depreciation And Amortization | 17,543,000USD | 334,434USD | 12,589USD | 11,198USD | 35,703USD | 19,780USD | — | — |
| Reconciled Depreciation | 17,543,000USD | — | — | — | — | — | — | — |
| Total Other Income Expense Net | -17,649,000USD | 836,576USD | 2,842USD | -32,315USD | -39,637USD | -46,250USD | 36,651USD | 27,484USD |
| Non Operating Income Net Other | -9,729,000USD | 836,576USD | -169,658USD | — | — | — | — | — |
| Minority Interest | 1,482,000USD | 454,644USD | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | 49,049,000USD | -1,802,601USD | -720,346USD | — | — | — | — | — |
| Research Development | — | 0USD | 0USD | — | — | — | — | — |
| Other Operating Expenses | — | — | — | — | — | — | 36,651USD | 27,484USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,358,827,000USD | 2,218,661,000USD | 2,237,186,000USD | 1,442,350,000USD | 1,331,256,000USD | 1,354,894,000USD | 1,285,376,000USD | 1,252,471,000USD |
| Intangible Assets | 257,118,000USD | 270,968,000USD | 285,060,000USD | 105,737,000USD | 111,916,000USD | 118,179,000USD | 109,108,000USD | 116,231,000USD |
| Other Current Assets | 25,647,000USD | 26,264,000USD | 23,162,000USD | 21,754,000USD | 23,711,000USD | 22,861,000USD | 20,506,000USD | 16,217,000USD |
| Total Liab | 1,781,371,000USD | 1,660,327,000USD | 1,682,462,000USD | 904,404,000USD | 813,550,000USD | 840,726,000USD | 778,269,000USD | 773,775,000USD |
| Total Stockholder Equity | 800,268,000USD | 779,291,000USD | 775,543,000USD | 765,461,000USD | 745,368,000USD | 712,720,000USD | 704,616,000USD | 678,874,000USD |
| Other Current Liab | 633,112,000USD | 512,098,000USD | 516,385,000USD | 427,598,000USD | 327,721,000USD | 333,555,000USD | 252,979,000USD | 246,511,000USD |
| Common Stock | 49,000USD | 49,000USD | 49,000USD | 49,000USD | 49,000USD | 48,000USD | 48,000USD | 48,000USD |
| Capital Stock | 49,000USD | 49,000USD | 49,000USD | 49,000USD | 49,000USD | 48,000USD | 48,000USD | 48,000USD |
| Retained Earnings | 322,711,000USD | 308,379,000USD | 302,486,000USD | 302,209,000USD | 292,880,000USD | 286,283,000USD | 293,234,000USD | 277,140,000USD |
| Good Will | 874,799,000USD | 863,944,000USD | 863,266,000USD | 416,917,000USD | 416,386,000USD | 419,253,000USD | 409,711,000USD | 409,581,000USD |
| Cash | 478,383,000USD | 429,474,000USD | 462,227,000USD | 339,703,000USD | 258,517,000USD | 288,455,000USD | 347,994,000USD | 325,310,000USD |
| Cash And Short Term Investments | 478,383,000USD | 429,474,000USD | 463,448,000USD | 342,120,000USD | 260,914,000USD | 290,833,000USD | 350,348,000USD | 327,693,000USD |
| Total Current Assets | 1,004,100,000USD | 863,313,000USD | 883,629,000USD | 729,152,000USD | 613,270,000USD | 638,496,000USD | 596,990,000USD | 569,149,000USD |
| Total Current Liabilities | 745,369,000USD | 615,273,000USD | 629,930,000USD | 459,746,000USD | 361,268,000USD | 365,608,000USD | 312,928,000USD | 309,825,000USD |
| Net Debt | 586,809,000USD | 648,656,000USD | 625,016,000USD | 107,887,000USD | 192,833,000USD | 183,384,000USD | 127,825,000USD | 150,142,000USD |
| Short Term Debt | 55,422,000USD | 55,674,000USD | 55,046,000USD | 17,819,000USD | 17,950,000USD | 15,279,000USD | 20,795,000USD | 22,475,000USD |
| Short Long Term Debt | 47,865,000USD | 47,865,000USD | 47,865,000USD | 12,500,000USD | 12,500,000USD | 9,375,000USD | 15,000,000USD | 17,000,000USD |
| Short Long Term Debt Total | 1,065,192,000USD | 1,078,130,000USD | 1,087,243,000USD | 447,590,000USD | 451,350,000USD | 471,839,000USD | 475,819,000USD | 475,452,000USD |
| Long Term Debt | 979,764,000USD | 990,904,000USD | 1,002,026,000USD | 401,057,000USD | 403,894,000USD | 425,299,000USD | 423,119,000USD | 425,006,000USD |
| Long Term Investments | 27,257,000USD | 28,533,000USD | 27,358,000USD | 47,350,000USD | 46,901,000USD | 48,215,000USD | 43,525,000USD | 42,172,000USD |
| Net Receivables | 500,070,000USD | 407,575,000USD | 397,019,000USD | 365,278,000USD | 328,645,000USD | 324,802,000USD | 226,136,000USD | 225,239,000USD |
| Accounts Payable | 54,328,000USD | 44,842,000USD | 58,499,000USD | 14,329,000USD | 14,911,000USD | 15,168,000USD | 36,908,000USD | 38,221,000USD |
| Property Plant Equipment Net | 93,479,000USD | 94,431,000USD | 90,100,000USD | 48,431,000USD | 47,547,000USD | 46,875,000USD | 45,291,000USD | 39,097,000USD |
| Property Plant Equipment Gross | 93,479,000USD | 122,744,000USD | 90,100,000USD | 48,431,000USD | 47,547,000USD | 71,563,000USD | 45,291,000USD | 39,097,000USD |
| Common Stock Shares Outstanding | 49,054,135shares | 49,527,521shares | 49,470,677shares | 49,470,677shares | 48,850,666shares | 47,929,872shares | 48,223,788shares | 47,978,491shares |
| Non Current Assets Total | 1,354,727,000USD | 1,355,348,000USD | 1,353,557,000USD | 713,198,000USD | 717,986,000USD | 716,398,000USD | 688,386,000USD | 683,322,000USD |
| Non Current Liabilities Total | 1,036,002,000USD | 1,045,054,000USD | 1,052,532,000USD | 444,658,000USD | 452,282,000USD | 475,118,000USD | 465,341,000USD | 463,950,000USD |
| Non Current Liabilities Other | 18,833,000USD | 17,107,000USD | 15,906,000USD | 12,294,000USD | 14,685,000USD | 14,003,000USD | 7,460,000USD | 7,723,000USD |
| Non Currrent Assets Other | 48,092,000USD | 100,368,000USD | 37,200,000USD | 94,763,000USD | 95,236,000USD | 95,992,000USD | 80,751,000USD | 26,032,000USD |
| Net Working Capital | 258,731,000USD | 248,040,000USD | 253,699,000USD | 269,406,000USD | 252,002,000USD | 272,888,000USD | 284,062,000USD | 260,524,000USD |
| Unclassified Non Current Assets | 53,982,000USD | — | 50,573,000USD | -322,840,000USD | — | -12,116,000USD | — | 50,209,000USD |
| Unclassified Current Liabilities | -45,358,000USD | -47,865,000USD | -47,865,000USD | -12,500,000USD | -12,500,000USD | -9,375,000USD | -15,000,000USD | -17,000,000USD |
| Unclassified Non Current Liabilities | 37,405,000USD | 37,043,000USD | 34,600,000USD | 31,307,000USD | 33,703,000USD | 35,816,000USD | 34,762,000USD | 31,221,000USD |
| Unclassified Equity | 477,459,000USD | 470,814,000USD | 472,959,000USD | 463,154,000USD | 452,390,000USD | 426,341,000USD | 411,286,000USD | 401,638,000USD |
| Current Deferred Revenue | — | 2,659,000USD | — | — | 686,000USD | 1,606,000USD | 2,246,000USD | 2,618,000USD |
| Short Term Investments | — | — | 1,221,000USD | 2,417,000USD | 2,397,000USD | 2,378,000USD | 2,354,000USD | 2,383,000USD |
| Other Assets | — | — | — | 322,840,000USD | — | -20,657,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,218,661,000USD | 1,354,894,000USD | 933,361,000USD | 966,213,000USD | 867,361,000USD | 817,486,000USD | 728,713,000USD | 512,999,049USD |
| Intangible Assets | 270,968,000USD | 118,179,000USD | 71,648,000USD | 76,861,000USD | 82,807,000USD | 86,985,000USD | 103,012,000USD | 86,875,883USD |
| Other Current Assets | 26,264,000USD | 22,861,000USD | 17,450,000USD | 14,798,000USD | 18,637,000USD | 16,797,000USD | 10,390,000USD | 7,385,098USD |
| Total Liab | 1,660,327,000USD | 840,726,000USD | 522,593,000USD | 407,666,000USD | 356,719,000USD | 372,338,000USD | 367,653,000USD | 106,337,868USD |
| Total Stockholder Equity | 779,291,000USD | 712,720,000USD | 614,218,000USD | 542,561,000USD | 448,167,000USD | 330,824,000USD | 191,549,000USD | 180,545,832USD |
| Other Current Liab | 512,098,000USD | 322,514,000USD | 184,102,000USD | 128,542,000USD | 88,513,000USD | 74,058,000USD | 72,496,000USD | 46,750,009USD |
| Common Stock | 49,000USD | 48,000USD | 47,000USD | 47,000USD | 45,000USD | 42,000USD | 36,000USD | 34,578USD |
| Capital Stock | 49,000USD | 48,000USD | 47,000USD | 47,000USD | 45,000USD | 42,000USD | 35,908USD | 34,578USD |
| Retained Earnings | 308,379,000USD | 286,283,000USD | 243,134,000USD | 182,417,000USD | 137,246,000USD | 69,771,000USD | 31,905,000USD | 17,788,203USD |
| Good Will | 863,944,000USD | 419,253,000USD | 278,831,000USD | 269,053,000USD | 246,416,000USD | 239,053,000USD | 238,505,000USD | 185,805,880USD |
| Cash | 429,474,000USD | 288,455,000USD | 293,807,000USD | 288,027,000USD | 233,097,000USD | 193,470,000USD | 103,189,000USD | 106,891,503USD |
| Cash And Short Term Investments | 429,474,000USD | 290,833,000USD | 296,305,000USD | 293,594,000USD | 286,514,000USD | 261,165,000USD | 219,728,000USD | 108,018,605USD |
| Total Current Assets | 863,313,000USD | 638,496,000USD | 461,507,000USD | 428,125,000USD | 404,460,000USD | 338,577,000USD | 329,068,000USD | 172,862,792USD |
| Total Current Liabilities | 615,273,000USD | 365,608,000USD | 218,674,000USD | 148,610,000USD | 114,719,000USD | 114,992,000USD | 105,424,000USD | 72,019,647USD |
| Current Deferred Revenue | 2,659,000USD | 1,606,000USD | 744,000USD | 531,000USD | 16,798,000USD | 12,988,000USD | 8,892,000USD | 9,024,235USD |
| Net Debt | 648,656,000USD | 183,384,000USD | 27,207,000USD | -58,663,000USD | -32,114,000USD | 67,085,000USD | 153,364,000USD | -93,232,244USD |
| Short Term Debt | 55,674,000USD | 15,279,000USD | 24,753,000USD | 4,785,000USD | 3,895,000USD | 14,168,000USD | 12,593,000USD | 141,998USD |
| Short Long Term Debt | 47,865,000USD | 9,375,000USD | 19,500,000USD | 619,000USD | 780,000USD | 10,889,000USD | 9,500,000USD | 40,257USD |
| Short Long Term Debt Total | 1,078,130,000USD | 471,839,000USD | 321,014,000USD | 229,364,000USD | 200,983,000USD | 260,555,000USD | 256,553,000USD | 13,659,259USD |
| Long Term Debt | 990,904,000USD | 425,299,000USD | 258,939,000USD | 203,389,000USD | 182,917,000USD | 230,211,000USD | 232,172,134USD | 13,000,000USD |
| Long Term Investments | 28,533,000USD | 48,215,000USD | 32,170,000USD | 40,299,000USD | 42,611,000USD | 47,917,000USD | 28,427,455USD | 52,376,980USD |
| Net Receivables | 407,575,000USD | 324,802,000USD | 147,752,000USD | 119,733,000USD | 99,309,000USD | 60,615,000USD | 98,950,000USD | 57,459,089USD |
| Accounts Payable | 44,842,000USD | 15,168,000USD | 9,075,000USD | 10,473,000USD | 5,513,000USD | 9,554,000USD | 6,914,000USD | 4,481,544USD |
| Property Plant Equipment Net | 94,431,000USD | 46,875,000USD | 44,567,000USD | 128,980,000USD | 68,627,000USD | 48,464,000USD | 26,378,000USD | 12,721,082USD |
| Property Plant Equipment Gross | 122,744,000USD | 71,563,000USD | 67,443,000USD | 128,980,000USD | 68,627,000USD | 48,464,000USD | 26,377,628USD | 12,721,082USD |
| Common Stock Shares Outstanding | 49,369,685shares | 48,223,788shares | 47,067,442shares | 45,602,415shares | 45,403,085shares | 37,448,430shares | 36,403,279shares | 37,914,886shares |
| Non Current Assets Total | 1,355,348,000USD | 716,398,000USD | 471,854,000USD | 538,088,000USD | 462,901,000USD | 478,909,000USD | 399,645,000USD | 340,136,257USD |
| Non Current Liabilities Total | 1,045,054,000USD | 475,118,000USD | 303,919,000USD | 259,056,000USD | 242,000,000USD | 257,346,000USD | 262,229,000USD | 34,318,220USD |
| Non Current Liabilities Other | 17,107,000USD | 14,003,000USD | 3,586,000USD | 41,450,000USD | 14,777,000USD | 16,176,000USD | 11,788,116USD | 14,185,025USD |
| Non Currrent Assets Other | 100,368,000USD | 63,219,000USD | 2,222,000USD | 4,556,000USD | 22,440,000USD | 19,415,000USD | 2,427,000USD | 1,205,962USD |
| Net Working Capital | 248,040,000USD | 272,888,000USD | 242,833,000USD | 287,809,000USD | 283,411,000USD | 223,585,000USD | 223,644,503USD | 100,843,145USD |
| Unclassified Current Liabilities | -47,865,000USD | — | -19,500,000USD | 3,660,000USD | — | -6,665,000USD | -4,971,000USD | 11,581,604USD |
| Unclassified Non Current Liabilities | 37,043,000USD | 35,816,000USD | 41,394,000USD | -12,127,000USD | 11,275,000USD | -10,959,000USD | -18,270,146USD | -33,283,700USD |
| Unclassified Equity | 470,814,000USD | 426,341,000USD | 370,990,000USD | 360,050,000USD | 310,831,000USD | 260,969,000USD | 175,595,268USD | 176,689,439USD |
| Other Assets | — | 417,695,000USD | 22,142,000USD | 6,056,000USD | 6,497,000USD | 55,286,000USD | 2,426,793USD | 19,451,432USD |
| Short Term Investments | — | 2,378,000USD | 2,498,000USD | 5,567,000USD | 53,417,000USD | 67,695,000USD | 116,539,000USD | 1,127,102USD |
| Unclassified Non Current Assets | — | -397,038,000USD | 20,274,000USD | 12,283,000USD | -6,497,000USD | -18,211,000USD | — | -18,300,962USD |
| Deferred Long Term Liab | — | — | — | 3,042,000USD | 9,127,000USD | 10,959,000USD | 18,269,448USD | 19,615,935USD |
| Other Liab | — | — | — | 23,302,000USD | 23,904,000USD | 10,959,000USD | 18,269,448USD | 20,800,960USD |
| Net Tangible Assets | — | — | — | 213,968,000USD | 118,704,000USD | 119,023,000USD | 18,756,482USD | 132,981,098USD |
| Inventory | — | — | — | — | -67,217,000USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | -16,023,176USD | -14,000,966USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 14,436,000USD | 6,562,000USD | 1,077,000USD | 10,216,000USD | 6,221,000USD | -7,777,000USD | 23,703,000USD | 21,866,000USD |
| Depreciation | 15,479,000USD | 16,401,000USD | 15,596,000USD | 6,903,000USD | 6,849,000USD | 8,126,000USD | 7,264,000USD | 7,441,000USD |
| Stock Based Compensation | 9,895,000USD | 11,382,000USD | 7,700,000USD | 11,708,000USD | 7,811,000USD | 15,235,000USD | 6,163,000USD | 7,390,000USD |
| Other Non Cash Items | -149,000USD | 1,355,000USD | 3,992,000USD | 4,824,000USD | 4,114,000USD | -349,000USD | -38,921,000USD | -547,000USD |
| Change In Working Capital | 26,488,000USD | -39,223,000USD | -15,446,000USD | 58,852,000USD | -8,010,000USD | -29,530,000USD | 36,109,000USD | -12,951,000USD |
| Total Cash From Operating Activities | 68,056,000USD | -2,886,000USD | 9,956,000USD | 90,900,000USD | 16,627,000USD | -10,948,000USD | 33,981,000USD | 23,188,000USD |
| Capital Expenditures | -4,000,000USD | -3,064,000USD | -2,552,000USD | -1,420,000USD | -3,070,000USD | -2,531,000USD | -2,295,000USD | -2,836,000USD |
| Free Cash Flow | 64,056,000USD | -5,950,000USD | 7,404,000USD | 89,480,000USD | 13,557,000USD | -13,479,000USD | 31,686,000USD | 20,352,000USD |
| Total Cashflows From Investing Activities | -2,844,000USD | -1,057,000USD | -534,471,000USD | -1,049,000USD | -2,394,000USD | -33,324,000USD | -8,107,000USD | -79,925,000USD |
| Net Borrowings | -11,967,000USD | -11,966,000USD | 655,334,000USD | -2,978,000USD | -16,379,000USD | -3,886,000USD | -2,195,000USD | — |
| Total Cash From Financing Activities | -15,960,000USD | -26,337,000USD | 648,491,000USD | -8,666,000USD | -44,170,000USD | -15,267,000USD | -3,190,000USD | 47,252,000USD |
| Dividends Paid | -104,000USD | -1,556,000USD | -96,000USD | -778,000USD | -5,455,000USD | -1,922,000USD | -218,000USD | -1,801,000USD |
| Sale Purchase Of Stock | -2,906,000USD | -15,429,000USD | -509,000USD | 1,316,000USD | -1,316,000USD | -220,000USD | -717,000USD | -3,584,000USD |
| Change In Cash | 48,909,000USD | -30,281,000USD | 122,524,000USD | 81,186,000USD | -29,937,000USD | -59,539,000USD | 22,684,000USD | -9,485,000USD |
| Begin Period Cash Flow | 429,474,000USD | 464,326,000USD | 339,703,000USD | 258,517,000USD | 289,101,000USD | 348,640,000USD | 325,956,000USD | 335,441,000USD |
| End Period Cash Flow | 478,383,000USD | 434,045,000USD | 462,227,000USD | 339,703,000USD | 259,164,000USD | 289,101,000USD | 348,640,000USD | 325,956,000USD |
| Other Cashflows From Investing Activities | 1,156,000USD | 2,058,000USD | 1,534,000USD | 419,000USD | 700,000USD | -10,000,000USD | -968,000USD | -750,000USD |
| Other Cashflows From Financing Activities | -983,000USD | 2,614,000USD | -23,479,000USD | -5,925,000USD | -21,020,000USD | -9,762,000USD | 112,000USD | -3,946,000USD |
| Unclassified Operating Cash Flow | 1,907,000USD | — | -2,963,000USD | -1,603,000USD | — | 3,347,000USD | — | — |
| Change To Account Receivables | — | — | 9,755,000USD | — | -9,755,000USD | 54,672,000USD | 50,687,000USD | -34,324,000USD |
| Investments | — | — | -534,471,000USD | -1,077,000USD | -2,394,000USD | -33,324,000USD | -8,107,000USD | -79,925,000USD |
| Unclassified Financing Cash Flow | — | — | 17,241,000USD | — | — | — | — | 56,583,000USD |
| Unclassified Investing Cash Flow | — | — | — | 1,029,000USD | 2,370,000USD | 12,531,000USD | 3,263,000USD | 3,586,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 24,076,000USD | 49,932,000USD | 57,849,000USD | 49,294,000USD | 122,320,000USD | 17,673,317USD | 10,835,002USD | 25,801,842USD |
| Depreciation | 45,749,000USD | 27,927,000USD | 17,748,000USD | 17,517,000USD | 18,350,000USD | 18,753,270USD | 19,303,179USD | 19,075,353USD |
| Stock Based Compensation | 38,601,000USD | 34,536,000USD | 22,040,000USD | 6,745,000USD | 3,383,000USD | 1,546,861USD | 1,441,000USD | 2,743,116USD |
| Other Non Cash Items | 13,556,000USD | 7,665,000USD | 6,422,000USD | 22,852,000USD | -102,084,000USD | 5,272,377USD | 157,261,463USD | 42,146,479USD |
| Change To Account Receivables | -7,163,000USD | -11,095,000USD | -20,568,000USD | -21,634,000USD | 3,011,000USD | 9,278,497USD | -28,626,299USD | 10,702,753USD |
| Change In Working Capital | -3,098,000USD | -63,613,000USD | -23,388,000USD | -20,121,000USD | 10,814,000USD | -22,771,523USD | -63,049,072USD | 15,982,676USD |
| Total Cash From Operating Activities | 114,597,000USD | 52,198,000USD | 68,227,000USD | 70,335,000USD | 46,163,000USD | 13,673,383USD | 26,103,450USD | 53,073,923USD |
| Capital Expenditures | -10,106,000USD | -8,031,000USD | -28,529,000USD | -19,223,000USD | -1,164,000USD | -1,041,670USD | -1,170,064USD | -2,084,769USD |
| Free Cash Flow | 104,491,000USD | 44,167,000USD | 39,698,000USD | 51,112,000USD | 44,999,000USD | 12,631,713USD | 24,933,386USD | 50,989,154USD |
| Total Cashflows From Investing Activities | -538,999,000USD | -192,395,000USD | -65,523,000USD | 16,540,000USD | 95,493,000USD | -180,630,636USD | -25,762,929USD | 6,730,789USD |
| Net Borrowings | 624,011,000USD | 152,705,000USD | 79,171,000USD | -57,965,000USD | -105,000USD | 281,351,815USD | 7,406,131USD | 4,897,652USD |
| Total Cash From Financing Activities | 569,346,000USD | 135,146,000USD | 3,421,000USD | -47,748,000USD | -51,696,000USD | 163,330,712USD | -11,203,643USD | -14,975,549USD |
| Dividends Paid | -7,885,000USD | -4,036,000USD | -62,074,000USD | -31,089,000USD | -51,319,000USD | -61,717,367USD | -17,758,808USD | -10,447,923USD |
| Sale Purchase Of Stock | -15,429,000USD | -937,000USD | -10,192,000USD | -5,739,000USD | -537,000USD | -7,569,685USD | -5,047,643USD | -3,175,836USD |
| Change In Cash | 144,944,000USD | -5,051,000USD | 6,125,000USD | 39,127,000USD | 89,960,000USD | -3,626,541USD | -12,880,794USD | 110,502,287USD |
| Begin Period Cash Flow | 289,101,000USD | 294,152,000USD | 288,027,000USD | 193,970,000USD | 104,010,000USD | 107,636,973USD | 119,772,297USD | 9,270,010USD |
| End Period Cash Flow | 434,045,000USD | 289,101,000USD | 294,152,000USD | 233,097,000USD | 193,970,000USD | 104,010,432USD | 106,891,503USD | 119,772,297USD |
| Other Cashflows From Investing Activities | 4,611,000USD | -25,744,000USD | -23,797,000USD | 56,000USD | -11,304,000USD | -49,893,514USD | -7,500,000USD | 26,795,842USD |
| Other Cashflows From Financing Activities | -12,146,000USD | -12,586,000USD | -3,484,000USD | 187,480,000USD | -1,037,000USD | 286,979,765USD | 3,996,357USD | -8,410,178USD |
| Unclassified Operating Cash Flow | -4,287,000USD | -4,249,000USD | -12,444,000USD | -5,952,000USD | -6,620,000USD | -6,800,919USD | -99,688,122USD | -52,675,543USD |
| Unclassified Investing Cash Flow | -533,504,000USD | 33,775,000USD | 52,326,000USD | 3,342,000USD | — | — | 6,514,889USD | -9,440,001USD |
| Unclassified Financing Cash Flow | -19,205,000USD | — | — | -140,435,000USD | 1,302,000USD | -335,713,816USD | — | 2,160,736USD |
| Investments | — | -192,395,000USD | -65,523,000USD | 32,365,000USD | 107,961,000USD | -129,695,452USD | -23,607,754USD | -8,540,283USD |
| Change To Inventory | — | — | 12,155,000USD | 1,025,000USD | -5,811,000USD | -29,562,909USD | -11,756,000USD | 8,871,489USD |
| Issuance Of Capital Stock | — | — | 0USD | 40,134,000USD | -2USD | 754,998USD | 200,000USD | — |
| Change To Liabilities | — | — | — | 3,217,000USD | 6,824,000USD | -13,879,213USD | -10,111,655USD | 2,362,429USD |
| Cash And Cash Equivalents Changes | — | — | — | 39,127,000USD | 89,960,000USD | -3,626,541USD | -10,863,122USD | 44,924,619USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Capitation Revenue | 892,908,000 | USD | 0001193125-26-213157 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Other | 12,486,000 | USD | 0001193125-26-213157 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service | 37,831,000 | USD | 0001193125-26-213157 |
| Q1 2026Quarterly · 2026-03-31 | Product | Management Service | 15,685,000 | USD | 0001193125-26-213157 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Other | 6,190,000 | USD | 0001193125-26-213157 |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Capitation Revenue | 862,814,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Other | 25,508,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Patient Service | 39,787,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Management Service | 10,290,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product And Service Other | 12,124,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Capitation Revenue | 2,924,265,000 | USD | 0001193125-26-103128 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Other | 86,199,000 | USD | 0001193125-26-103128 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Patient Service | 112,635,000 | USD | 0001193125-26-103128 |
| FY 2025Yearly · 2025-12-31 | Product | Management Service | 30,394,000 | USD | 0001193125-26-103128 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Other | 28,276,000 | USD | 0001193125-26-103128 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Capitation Revenue | 863,380,000 | USD | 0001193125-25-274359 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Other | 30,798,000 | USD | 0001193125-25-274359 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Patient Service | 40,080,000 | USD | 0001193125-25-274359 |
| Q3 2025Quarterly · 2025-09-30 | Product | Management Service | 15,217,000 | USD | 0001193125-25-274359 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Other | 6,573,000 | USD | 0001193125-25-274359 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Capitation Revenue | 614,108,000 | USD | 0000950170-25-105242 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Other | 15,402,000 | USD | 0000950170-25-105242 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Patient Service | 17,878,000 | USD | 0000950170-25-105242 |
| Q2 2025Quarterly · 2025-06-30 | Product | Management Service | 2,577,000 | USD | 0000950170-25-105242 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Other | 4,843,000 | USD | 0000950170-25-105242 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Capitation Revenue | 583,963,000 | USD | 0001193125-26-213157 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Other | 14,491,000 | USD | 0001193125-26-213157 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service | 14,890,000 | USD | 0001193125-26-213157 |
| Q1 2025Quarterly · 2025-03-31 | Product | Management Service | 2,310,000 | USD | 0001193125-26-213157 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Other | 4,736,000 | USD | 0001193125-26-213157 |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Capitation Revenue | 616,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Other | 28,660,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Patient Service | 7,743,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Management Service | 5,550,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product And Service Other | 6,356,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Capitation Revenue | 1,856,785,000 | USD | 0001193125-26-103128 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Other | 86,224,000 | USD | 0001193125-26-103128 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Patient Service | 62,331,000 | USD | 0001193125-26-103128 |
| FY 2024Yearly · 2024-12-31 | Product | Management Service | 13,979,000 | USD | 0001193125-26-103128 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Other | 15,221,000 | USD | 0001193125-26-103128 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Capitation Revenue | 431,401,000 | USD | 0001193125-25-274359 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Other | 21,779,000 | USD | 0001193125-25-274359 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Patient Service | 18,692,000 | USD | 0001193125-25-274359 |
| Q3 2024Quarterly · 2024-09-30 | Product | Management Service | 2,747,000 | USD | 0001193125-25-274359 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product And Service Other | 4,091,000 | USD | 0001193125-25-274359 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Capitation Revenue | 442,574,000 | USD | 0000950170-25-105242 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Other | 18,408,000 | USD | 0000950170-25-105242 |
| Q2 2024Quarterly · 2024-06-30 | Product | Health Care Patient Service | 19,959,000 | USD | 0000950170-25-105242 |
| Q2 2024Quarterly · 2024-06-30 | Product | Management Service | 1,604,000 | USD | 0000950170-25-105242 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product And Service Other | 3,720,000 | USD | 0000950170-25-105242 |
| FY 2023Yearly · 2023-12-31 | Product | Health Care Capitation Revenue | 1,215,614,000 | USD | 0001193125-26-103128 |
| FY 2023Yearly · 2023-12-31 | Product | Health Care Other | 63,468,000 | USD | 0001193125-26-103128 |
| FY 2023Yearly · 2023-12-31 | Product | Health Care Patient Service | 59,658,000 | USD | 0001193125-26-103128 |
| FY 2023Yearly · 2023-12-31 | Product | Management Service | 38,677,000 | USD | 0001193125-26-103128 |
| FY 2023Yearly · 2023-12-31 | Product | Product And Service Other | 9,244,000 | USD | 0001193125-26-103128 |
| FY 2022Yearly · 2022-12-31 | Product | Health Care Capitation Revenue | 930,131,000 | USD | 0001628280-24-008024 |
| FY 2022Yearly · 2022-12-31 | Product | Health Care Other | 117,254,000 | USD | 0001628280-24-008024 |
| FY 2022Yearly · 2022-12-31 | Product | Health Care Patient Service | 49,517,000 | USD | 0001628280-24-008024 |
| FY 2022Yearly · 2022-12-31 | Product | Management Service | 41,094,000 | USD | 0001628280-24-008024 |
| FY 2022Yearly · 2022-12-31 | Product | Product And Service Other | 6,167,000 | USD | 0001628280-24-008024 |
| FY 2021Yearly · 2021-12-31 | Product | Health Care Capitation Revenue | 593,224,000 | USD | 0001628280-24-008024 |
| FY 2021Yearly · 2021-12-31 | Product | Health Care Other | 111,627,000 | USD | 0001628280-24-008024 |
| FY 2021Yearly · 2021-12-31 | Product | Health Care Patient Service | 26,564,000 | USD | 0001628280-24-008024 |
| FY 2021Yearly · 2021-12-31 | Product | Management Service | 35,959,000 | USD | 0001628280-24-008024 |
| FY 2021Yearly · 2021-12-31 | Product | Product And Service Other | 6,541,000 | USD | 0001628280-24-008024 |
| FY 2020Yearly · 2020-12-31 | Product | Health Care Capitation Revenue | 557,326,000 | USD | 0001628280-23-005871 |
| FY 2020Yearly · 2020-12-31 | Product | Health Care Other | 77,367,000 | USD | 0001628280-23-005871 |
| FY 2020Yearly · 2020-12-31 | Product | Health Care Patient Service | 12,683,000 | USD | 0001628280-23-005871 |
| FY 2020Yearly · 2020-12-31 | Product | Management Service | 34,850,000 | USD | 0001628280-23-005871 |
| FY 2020Yearly · 2020-12-31 | Product | Product And Service Other | 4,954,000 | USD | 0001628280-23-005871 |
| FY 2019Yearly · 2019-12-31 | Product | Health Care Capitation Revenue | 454,168,000 | USD | 0001628280-22-004291 |
| FY 2019Yearly · 2019-12-31 | Product | Health Care Other | 51,098,000 | USD | 0001628280-22-004291 |
| FY 2019Yearly · 2019-12-31 | Product | Health Care Patient Service | 15,475,000 | USD | 0001628280-22-004291 |
| FY 2019Yearly · 2019-12-31 | Product | Management Service | 34,668,000 | USD | 0001628280-22-004291 |
| FY 2019Yearly · 2019-12-31 | Product | Product And Service Other | 5,209,000 | USD | 0001628280-22-004291 |
| FY 2018Yearly · 2018-12-31 | Product | Health Care Capitation Revenue | 344,307,000 | USD | 0001628280-21-004679 |
| FY 2018Yearly · 2018-12-31 | Product | Health Care Other | 100,928,000 | USD | 0001628280-21-004679 |
| FY 2018Yearly · 2018-12-31 | Product | Health Care Patient Service | 19,704,000 | USD | 0001628280-21-004679 |
| FY 2018Yearly · 2018-12-31 | Product | Management Service | 49,743,000 | USD | 0001628280-21-004679 |
| FY 2018Yearly · 2018-12-31 | Product | Product And Service Other | 5,226,000 | USD | 0001628280-21-004679 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.